OmniAb, Inc.

NASDAQ:OABI

Biotechnology

Healthcare
$5.08 +7.88%

+$0.16 today

Market cap
$740.97M
Beta
1.15
P/E (TTM)
-5.2
EPS (TTM)
-$0.42
52W Low $1.30High $2.79

Volume 1.22M

Average 0.67M

OABI Other Income / Expenses

Net non-operating gains and losses, such as investment results, currency effects, and one-off items.

OmniAb, Inc.NASDAQ: OABI

Other Income / Expenses · Q1 FY2026 · quarter ended Mar 2026

Other income / expenses dips below year-ago levels

Q1 FY2026 other income / expenses of $200K fell 62.8% year over year, behind the +71.8% change in trailing-twelve-month other income / expenses. Sequentially, it fell 81.8% from the prior quarter. Over 3 fiscal years it compounded at +107.2% a year.

Context

  • Other income / expenses amounted to 28.0% of revenue in FY2025, up 16.3 pp from a year earlier.
  • Other income / expenses increased in 2 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from -62.8% toward the trailing-twelve-month pace of +71.8%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
$200K-81.8% QoQ
Last fiscal yearDec 2025
$5.22M+69.0% YoY
LTMMar 2026
$4.56M+71.8% YoY
Other Income / Expenses past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-62.8%——
1 year+69.0%——
3-year CAGR+107.2%——
5-year CAGR——
10-year CAGR——

Other Income / Expenses history

USD · from the income statement

Latest · FY2025
5.22M USD
Year-over-year change
+69.0%
4-year CAGR
+42.7%

Other Income / Expenses vs competitors

How OABI compares with its peers on the latest reported figures

  • OABI's LTM Mar 2026 other income / expenses of $4.56M is the 2nd highest of the 4 companies compared; the peer median is -$7.37M.
  • Its year-over-year change of +71.8% is the 2nd highest of 4, against a peer median of -116.5%.
  • Other income / expenses amounts to 15.8% of revenue for OABI, versus a peer median of 38.8%.
OABI Competitors Peer median
Other Income / Expenses for OABI and competitors
Company Period LTM YoY 3-year CAGR% of revenue
ABSIAbsci CorporationLTM Mar 2026$10.19M +78.9%+90.7%555.0%
OABIOmniAb, Inc.LTM Mar 2026$4.56M +71.8%+107.2%15.8%
MGNXMacroGenics, Inc.LTM Mar 2026-$7.37M -116.5%—4.7%
STROSutro Biopharma, Inc.LTM Mar 2026-$38.64M -613.7%—38.8%
VRXAVeraxa Biotech Holding AG—— ———
Peer median (excluding OABI) -$7.37M-116.5%+90.7%38.8%

Competitors are the stored peer set for OABI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue34.75M59.08M34.16M26.39M18.67M
Cost of Revenue000022.06M
Gross Profit34.75M59.08M34.16M26.39M(3.39M)
Gross Margin100.0%100.0%100.0%100.0%-18.2%
Research & Development39.23M48.36M56.53M55.11M47.75M
Selling, General & Admin16.95M24.9M33.31M30.74M29.22M
Operating Expenses70.36M85.73M103.58M100.89M68.13M
Depreciation & Amortization16.25M18.25M19.5M23.58M21.75M
EBITDA(18.09M)(7.81M)(44.87M)(47.83M)(44.54M)
EBITDA Margin-52.1%-13.2%-131.3%-181.2%-238.6%
Operating Income(35.61M)(26.65M)(69.42M)(74.5M)(71.52M)
Operating Margin-102.5%-45.1%-203.2%-282.3%-383.1%
Interest Income0587K5.06M3.11M2.66M
Interest Expense7K0000
Other Income / Expenses1.26M587K5.06M3.09M5.22M
Income Before Tax(34.35M)(26.06M)(64.36M)(71.41M)(66.29M)
Pre-Tax Margin-98.9%-44.1%-188.4%-270.6%-355.2%
Income Tax Expense(7.31M)(3.73M)(13.74M)(9.38M)(1.52M)
Net Income(27.04M)(22.33M)(50.62M)(62.03M)(64.78M)
Net Margin-77.8%-37.8%-148.2%-235.1%-347.0%
EPS (Basic)(0.24)(0.26)(0.51)(0.61)(0.57)
EPS (Diluted)(0.24)(0.26)(0.51)(0.61)(0.57)
Weighted Avg Shares114.82M85.32M99.68M102.37M113.64M
Weighted Avg Shares (Diluted)114.82M85.32M99.68M102.37M113.64M

OmniAb, Inc.

NASDAQ:OABI

Intrinsic Alpha fair value

Locked

Current Price

$5.08

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.